MIT-spinoff Organogenesis announced today that its PuraPly antimicrobial wound care device is now available in a 1.6-cm disc size.
The Canton, Mass.-based company’s PuraPly AM product includes a broad-spectrum antibiotic, polyhexamethylene biguanide, embedded into a purified native collagen matrix. The device is cleared to treat an array of wound types, including pressure ulcers, surgical wounds, trauma wounds and diabetic ulcers.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!